1
|
Poruban T, Hunavy M, Farkas D, Carnoky S, Jakubova M. A rare Serratia marcescens-associated acute endocarditis of a tricuspid valve in an intravenous drug user : A case report and literature review. Wien Klin Wochenschr 2023; 135:631-636. [PMID: 37256420 DOI: 10.1007/s00508-023-02217-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2023] [Accepted: 04/20/2023] [Indexed: 06/01/2023]
Abstract
Serratia marcescens is a gram-negative bacillus that is an opportunistic agent in respiratory tract infections, urinary tract infections, and septicemia. It is rarely also a cause of infective endocarditis which follows a rapid and devastating course, typically in persons with history of intravenous drug use (IDU). This article reports a fatal case of a 27-year-old patient with a known history of IDU, who presented with clinical symptoms concerning right-sided endocarditis as well as signs of acute respiratory distress syndrome. Finally, a detailed review of the literature is provided concerning the acute endocarditis of a tricuspid valve, especially associated with Serratia marcescens infection.
Collapse
Affiliation(s)
- Tibor Poruban
- 1st Cardiological Clinic, East Slovak Institute of Cardiovascular Diseases, Pavol Jozef Safarik University, Ondavska 8, 040 11, Kosice, Slovakia.
| | - Mikulas Hunavy
- 1st Cardiological Clinic, East Slovak Institute of Cardiovascular Diseases, Pavol Jozef Safarik University, Ondavska 8, 040 11, Kosice, Slovakia
| | | | - Stanislav Carnoky
- 1st Cardiological Clinic, East Slovak Institute of Cardiovascular Diseases, Pavol Jozef Safarik University, Ondavska 8, 040 11, Kosice, Slovakia
| | - Marta Jakubova
- 1st Cardiological Clinic, East Slovak Institute of Cardiovascular Diseases, Pavol Jozef Safarik University, Ondavska 8, 040 11, Kosice, Slovakia
| |
Collapse
|
2
|
Mori M, Amabile A, Weimer MB, Geirsson A. The opioid epidemic and endocarditis: Frontiers in the management of injection drug use-related endocarditis. JTCVS OPEN 2021; 8:315-320. [PMID: 36004152 PMCID: PMC9390675 DOI: 10.1016/j.xjon.2021.05.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/15/2020] [Accepted: 05/11/2021] [Indexed: 06/15/2023]
Affiliation(s)
- Makoto Mori
- Division of Cardiac Surgery, Department of Surgery, Yale University School of Medicine, New Haven, Conn
| | - Andrea Amabile
- Division of Cardiac Surgery, Department of Surgery, Yale University School of Medicine, New Haven, Conn
| | - Melissa B. Weimer
- Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn
| | - Arnar Geirsson
- Division of Cardiac Surgery, Department of Surgery, Yale University School of Medicine, New Haven, Conn
| |
Collapse
|
3
|
El-Dalati S, Yoon P, Deeb GM. Is It Time to Rethink Public Reporting of Surgical Endocarditis Outcomes in Patients Who Inject Drugs? J Am Heart Assoc 2021; 10:e020090. [PMID: 33955234 PMCID: PMC8200709 DOI: 10.1161/jaha.120.020090] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Affiliation(s)
- Sami El-Dalati
- Division of Infectious Diseases Department of Internal Medicine University of Pittsburgh Medical Center Pittsburgh PA
| | - Pyongsoo Yoon
- Division of Cardiac Surgery and Heart Transplant Department of Cardiothoracic Surgery University of Pittsburgh Medical Center Pittsburgh PA
| | - George Michael Deeb
- Department of Cardiac Surgery University of Michigan Health Systems Ann Arbor MI
| |
Collapse
|
4
|
Cannon JW, Hayanga JA, Drvar TB, Ellison M, Cook C, Salman M, Roberts H, Badhwar V, Hayanga HK. A 34-Year-Old Male Intravenous Drug User with a Third Episode of Tricuspid Valve Endocarditis Treated with Repeat Valve Surgery. AMERICAN JOURNAL OF CASE REPORTS 2021; 22:e927385. [PMID: 33776054 PMCID: PMC8021270 DOI: 10.12659/ajcr.927385] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2020] [Revised: 02/19/2021] [Accepted: 01/15/2021] [Indexed: 12/27/2022]
Abstract
BACKGROUND Intravenous drug use is an epidemic in the United States. One of the complications of intravenous drug use can be infective endocarditis. The treatment for this disease is a combination of intravenous antibiotics, cardiac surgery consultation, and multidisciplinary psychiatric care. Despite surgical intervention, recurrence of disease is common. In the setting of recurrent infective endocarditis in the setting of intravenous drug use, the ethics of redo cardiac surgery has not been well-established. CASE REPORT A 34-year-old man with history of intravenous drug use presented on 3 separate occasions with infective endocarditis resulting in 3 tricuspid valve surgeries within fewer than 7 months. He said he had not injected drugs since before his first operation, he was considered to have a strong social support system, and he completed his postoperative antibiotic regimens each time. However, prior to his last operation, the patient had a urine drug screen positive for opiates without recorded prescribed opioids. Pathology reports from the 3 intraoperative specimens showed different pathogens each time. An extensive interprofessional discussion ensued. CONCLUSIONS Infective endocarditis in the setting of intravenous drug use and its treatments continue to be a point of ethical and medical discussion for all professionals involved with the care of these patients. This case could be used as an example of individualized decision-making, with rigorous ethical and medical discussion factoring into each decision for cardiac surgery. The ongoing treatment for patients with recurrent endocarditis in the setting of intravenous drug use requires more research and guidelines to help medical professionals better care for this patient population.
Collapse
Affiliation(s)
- Jeffrey W. Cannon
- Department of Anesthesiology and Perioperative Medicine, University Hospitals/Case Western Reserve University, Cleveland, OH, U.S.A
| | - J.W. Awori Hayanga
- Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WV, U.S.A
| | - Thomas B. Drvar
- Department of Behavioral Medicine and Psychiatry, West Virginia University, Morgantown, WV, U.S.A
| | - Matthew Ellison
- Division of Cardiovascular and Thoracic Anesthesiology, Department of Anesthesiology, West Virginia University, Morgantown, WV, U.S.A
| | - Christopher Cook
- Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WV, U.S.A
| | - Muhammad Salman
- Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WV, U.S.A
| | - Harold Roberts
- Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WV, U.S.A
| | - Vinay Badhwar
- Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WV, U.S.A
| | - Heather K. Hayanga
- Division of Cardiovascular and Thoracic Anesthesiology, Department of Anesthesiology, West Virginia University, Morgantown, WV, U.S.A
| |
Collapse
|